Oct 20 (Reuters) – AstraZeneca said on Tuesday that it is working with Oracle to use AI and real-world data to identify eligible patients for clinical trials and monitor safety signals, among other
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(Recasts, adds more from economy ministry statement) By Faith Hung and Jeanny Kao TAIPEI, Oct…
ROME, Oct 20 (Reuters) - Italian banks, insurers and other financial institutions including state lender…
By Samuel Indyk and Gregor Stuart Hunter LONDON, Oct 20 (Reuters) - The euro rebounded…
By Kentaro Okasaka and Tamiyuki Kihara TOKYO, Oct 20 (Reuters) - Japan is in the…
(Adds South Korean marine general's comment in paragraphs 13-14) * South Korea vows to punish…
* Japanese 20-year bond auction draws record demand, supports yen * UK jobs data shows…